Bloomberg Law
Dec. 18, 2019, 4:27 PM

Allergan Breast Implant Cancer Suits Head for New Jersey

Julie Steinberg
Julie Steinberg

Federal lawsuits linking Allergan Inc.‘s textured Biocell breast implants with a rare cancer will be combined and sent to New Jersey, where the company is headquartered, a special panel ruled Dec. 18.

Allergan recalled the implants in July after the Food and Drug Administration said the products had been associated with breast implant-associated anaplastic large cell lymphoma, a cancer of the immune system.

The lawsuits followed soon after. Women allege Allergan failed to disclose a link between the implants and the immune system cancer, and offered an insufficient program to cover medical costs.

The suits share complex fact questions ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.